The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.
The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately.
Prices for generic drugs may be dropping, but increases in branded and specialty drug prices have offset those decreases, according to a new study.
A drug under development by Forest Labs and Pierre Fabre "significantly" reduced symptoms of major depressive disorder, the companies said Wednesday.
A new drug for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim is available in pharmacies, the companies said Wednesday.
The Food and Drug Administration has declined to approve a drug made by Eisai for leukemia in certain elderly patients, the drug maker said.
Drug maker Shire will conduct two post-marketing trials to compare its treatment for attention deficit hyperactivity disorder with a competing drug, the company said Tuesday.
The Food and Drug Administration is asking for additional data before it approves a new cholesterol drug made by Merck, the drug maker said.
The Food and Drug Administration has approved a new formulation of a drug for postmenopausal women.
A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.